UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20449
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number:
ARBOR DRUGS, INC.
(Exact name of registrant as specified in its charter)
3331 West Big Beaver
Troy, MI 48084-2510
248-643-9420
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, Par Value $0.01 Per Share
(Title of each class of securities covered by this Form)
(Title of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [X]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice date:
None
Pursuant to the requirements of the Securities Exchange Act of 1934, Arbor
Drugs, Inc. has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
ARBOR DRUGS, INC.
Date: April 7, 1998 By /s/ Zenon P. Lankowsky
-----------------------------
Name: Zenon P. Lankowsky
Title: Vice President and Secretary
